Literature DB >> 599885

Dietary, bacterial, and host genetic interactions in the pathogenesis of transmissible murine colonic hyperplasia.

S W Barthold, G W Osbaldiston, A M Jonas.   

Abstract

Transmissible murine colonic hyperplasia, cuased by a variant of Citrobacter freundii (4280). was shown to be modified by diet and by host strain and species. Four different diets fed to mice inoculated with C frundii 4280 were found to have a significant but varying influence on the severity of hyperplasia. Diet also influenced the colonic crypt height of uninoculated, control mice. F344 rats, Syrian hamsters, and NIH Swiss [N:(S)], C57BL/6J, C3H/HeJ, and DBA/2J mice were inoculated with C freundii 4280. Marked strain differences were noted in the mice in mortality and severity of the colonic hyperplasia. The NIH Swiss mice had the greatest and the C57BL/6J mice had the least mucosal hyperplasia. The rats and hamsters did not develop disease or maintain infection after inoculation with the organism. Twenty isolates of Citrobacter from a range of biologic sources were inoculated into susceptible mice, but only mice inoculated with C freundii 4280 developed the disease.

Entities:  

Mesh:

Year:  1977        PMID: 599885

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  30 in total

1.  Distinct compartmentalization of NF-κB activity in crypt and crypt-denuded lamina propria precedes and accompanies hyperplasia and/or colitis following bacterial infection.

Authors:  Parthasarathy Chandrakesan; Ishfaq Ahmed; Anisha Chinthalapally; Pomila Singh; Shanjana Awasthi; Shrikant Anant; Shahid Umar
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  Chromosomal complementation using Tn7 transposon vectors in Enterobacteriaceae.

Authors:  Sébastien Crépin; Josée Harel; Charles M Dozois
Journal:  Appl Environ Microbiol       Date:  2012-06-15       Impact factor: 4.792

3.  Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice.

Authors:  Mohammed A Khan; Caixia Ma; Leigh A Knodler; Yanet Valdez; Carrie M Rosenberger; Wanyin Deng; B Brett Finlay; Bruce A Vallance
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

4.  La gestion sanitaire des élevages de rongeurs utilisés en recherche biomédicale: I. La nécessité de disposer d'animaux homogènes dans leur réaction.

Authors:  G Lussier
Journal:  Can Vet J       Date:  1986-02       Impact factor: 1.008

Review 5.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

6.  Citrobacter rodentium, the causative agent of transmissible murine colonic hyperplasia, exhibits clonality: synonymy of C. rodentium and mouse-pathogenic Escherichia coli.

Authors:  S A Luperchio; J V Newman; C A Dangler; M D Schrenzel; D J Brenner; A G Steigerwalt; D B Schauer
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

7.  Development of fatal colitis in FVB mice infected with Citrobacter rodentium.

Authors:  Diana Borenshtein; Prashant R Nambiar; Elizabeth B Groff; James G Fox; David B Schauer
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

Review 8.  Bacterial oncogenesis in the colon.

Authors:  Christine Dejea; Elizabeth Wick; Cynthia L Sears
Journal:  Future Microbiol       Date:  2013-04       Impact factor: 3.165

9.  Genetic and biochemical characterization of Citrobacter rodentium sp. nov.

Authors:  D B Schauer; B A Zabel; I F Pedraza; C M O'Hara; A G Steigerwalt; D J Brenner
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

10.  Evidence of functional cross talk between the Notch and NF-κB pathways in nonneoplastic hyperproliferating colonic epithelium.

Authors:  Ishfaq Ahmed; Badal Roy; Parthasarathy Chandrakesan; Anand Venugopal; Lijun Xia; Roy Jensen; Shrikant Anant; Shahid Umar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-11-29       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.